Gem Aromatics AGM passes all resolutions with 99.97% support

2 min read     Updated on 19 Aug 2026, 09:09 PM
scanx
Reviewed by
Jubin VScanX News Team
AI Summary

Gem Aromatics Limited shareholders approved FY26 financials and board changes at its August 19, 2026 AGM. Voting results show 99.97% support overall, with promoters voting 100% in favour. Key appointments include Mr. Dinesh Vasu Thekkepanakkal as WTD and Mr. Nandan Narula as Independent Director.

powered bylight_fuzz_icon
48698690

*this image is generated using AI for illustrative purposes only.

Gem Aromatics Limited shareholders approved the company’s audited financial statements for the fiscal year ended March 31, 2026, during its 29th Annual General Meeting held on August 19, 2026. The meeting, conducted via video conferencing in compliance with SEBI Listing Regulations and the Companies Act 2013, focused on board restructuring, director remuneration approvals, and the adoption of standalone and consolidated financial statements.

The statutory auditors, M/s. Chhajed & Doshi, Chartered Accountants, issued an unqualified report for FY26, with no adverse remarks or qualifications noted in either the Auditor’s Report or the Secretarial Auditor’s Report from M/s. N. L. Bhatia & Associates.

Voting Results Overview

The scrutinizer’s report reveals strong shareholder backing for all 13 resolutions. Out of a total shareholding of 5,22,37,138 shares, approximately 4,13,07,542 votes were polled, representing a 79.08% participation rate. Promoter and promoter group shareholders, holding 3,00,08,139 shares, voted unanimously (100%) in favour of every resolution through remote e-voting.

Public institutional shareholders, holding 30,65,424 shares, also cast all their polled votes (15,29,258) in favour. Dissent was minimal among public non-institutional shareholders, who hold 1,91,63,575 shares. Across most resolutions, more than 99.8% of polled votes from this segment were in favour.

Board Appointments and Reappointments

Shareholders passed ordinary resolutions to reappoint Mrs. Kaksha Vipul Parekh, who retires by rotation, as a director. Similarly, Mr. Yash Parekh, Managing Director and Chief Executive Officer, was reappointed after retiring by rotation.

The meeting also approved several special resolutions regarding board composition:

  • Appointment of Mr. Dinesh Vasu Thekkepanakkal as a Whole-Time Director effective May 21, 2026.
  • Appointment of Mr. Nandan Narula as a Non-Executive Independent Director for a five-year term starting May 21, 2026.
  • Approval of consultancy fees for Mr. Shrenik Kishorbhai Vora, Non-Executive Non-Independent Director.

Remuneration packages for the balance of their current terms were approved for Mrs. Kaksha Vipul Parekh (Whole-Time Director and CFO), Mr. Yash Parekh (MD & CEO), and Mr. Vipul Parekh (Whole-Time Director).

Governance and Auditors

The company ratified the remuneration for M/s. Y. R. Doshi & Associates Cost Accountants as Cost Auditors for FY27. Additionally, M/s. N. L. Bhatia & Associates were appointed as Secretarial Auditors.

During the proceedings, Mrs. Kaksha Vipul Parekh recused herself from voting on agenda items related to her own appointment and remuneration, as well as those concerning other interested directors. Mr. Nandan Narula, Independent Director and Chairman of the Audit Committee, assumed the chair for these specific items to ensure compliance with conflict-of-interest protocols.

What the Numbers Show

The presence of 62 members at the AGM, comprising seven promoters and 55 public shareholders, indicates broad participation in the governance process. The clean audit report for FY26 suggests no material irregularities in financial reporting or corporate functioning during the period under review. The near-unanimous support from both promoter and public shareholders underscores confidence in the board’s proposed strategic and governance changes.

The meeting concluded at 1:07 pm IST after a question-and-answer session where management addressed member queries regarding company operations and strategy.

Historical Stock Returns for Gem Aromatics

1 Day5 Days1 Month6 Months1 Year5 Years
+3.20%-3.25%-5.05%-10.13%-44.98%-44.98%

How will the appointment of Mr. Dinesh Vasu Thekkepanakkal as Whole-Time Director influence Gem Aromatics' operational strategy and cost management for FY27?

What specific growth initiatives or capital allocation plans did management outline during the AGM Q&A session to justify the approved remuneration packages for key executives?

Given the clean audit report, are there any pending regulatory observations or internal control improvements planned to maintain this standard in the upcoming fiscal year?

Gem Aromatics Q1FY27 revenue up 9% to ₹830 crore; EBITDA falls 43%

2 min read     Updated on 13 Aug 2026, 08:24 PM
scanx
Reviewed by
Suketu GScanX News Team
AI Summary

Gem Aromatics Limited reported Q1FY27 revenue of ₹830 crore, an 8.6% increase from ₹764 crore in the prior year period. EBITDA contracted 42.8% to ₹85 crore with margins slipping to 10.18%. Standalone net profit rose 12.3% to ₹73 crore. The company has scheduled an earnings call for August 14, 2026, to discuss these results.

powered bylight_fuzz_icon
48011283

*this image is generated using AI for illustrative purposes only.

Gem Aromatics Limited reported a mixed financial performance for the quarter ended June 30, 2026 (Q1FY27), with top-line growth offset by a sharp contraction in operating profitability. Revenue stood at ₹830 crore, rising 8.6% from ₹764 crore in the corresponding quarter of the previous fiscal year. However, earnings before interest, taxes, depreciation and amortisation (EBITDA) fell 42.8% to ₹85 crore, down from ₹148.5 crore in Q1FY26.

The decline in operating profit led to a significant compression in margins. The EBITDA margin for the quarter was 10.18%, compared to 16.95% in the prior year period. Despite the pressure on operating metrics, standalone net profit increased 12.3% to ₹73 crore, up from ₹65 crore in Q1FY26.

What the Numbers Show

The divergence between revenue growth and operating profit contraction highlights margin pressure during the quarter. While topline expanded by nearly 9%, EBITDA declined by over 40%, indicating that cost structures or input prices may have risen faster than sales realizations. The net profit increase, despite lower EBITDA, suggests potential contributions from other income or tax benefits, though specific breakdowns were not detailed in the initial disclosure.

Metric Q1FY27 Q1FY26 Change
Revenue ₹830 crore ₹764 crore +8.6%
EBITDA ₹85 crore ₹148.5 crore -42.8%
EBITDA Margin 10.18% 16.95% -677 bps
Standalone Net Profit ₹73 crore ₹65 crore +12.3%

Earnings Call Details

Gem Aromatics will host an investors and analysts conference call on August 14, 2026, at 4:00 p.m. IST to discuss these unaudited financial results. This disclosure serves as a procedural intimation under Regulation 30 read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The conference call aims to provide clarity on the company’s operational and financial performance for Q1FY27. Investors and analysts can dial in using the primary numbers +91 22 6280 1256 or +91 22 7115 8157. International participants may use toll-free numbers provided for Hong Kong, Singapore, the UK, and the USA. A Diamond Pass link is also available for online access.

Management Participation

Senior leadership from Gem Aromatics will address queries during the session. The participating executives include:

Name Designation
Yash Parekh MD & CEO
Kaksha Parekh WTD, Chairperson & CFO
Shrenik Vora Non-executive Director
Aadit Shah CEO's Office

Contact Information

For further information regarding the earnings call, investors may contact Akhilesh Gandhi, CFA, or Omkar Sawant via email at akhilesh@stellar-ir.com or omkar@stellar-ir.com . The contact number is +91 22 6239 8024. The company secretary and compliance officer, Akshita Deepak Gohil, signed the disclosure letter dated August 11, 2026.

Historical Stock Returns for Gem Aromatics

1 Day5 Days1 Month6 Months1 Year5 Years
+3.20%-3.25%-5.05%-10.13%-44.98%-44.98%

What specific input cost increases or pricing pressures contributed to the 677 basis point compression in EBITDA margins despite revenue growth?

How will management address the divergence between declining operating profitability and rising standalone net profit in future quarters?

What strategic initiatives are planned to restore EBITDA margins to the previous fiscal year's levels of approximately 17%?

More News on Gem Aromatics

1 Year Returns:-44.98%